The Age-Old Struggle against the AntivaccinationistsAnother emerging arbovirus, another emerging vaccine: Targeting Zika virusVaccinology in the third millennium: scientific and social challengesLessons learned in the analysis of high-dimensional data in vaccinomicsHigh-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titersGenome-wide association study of antibody response to smallpox vaccineTrends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomicsImmunization of Health-Care Providers: Necessity and Public Health PoliciesCytokine production associated with smallpox vaccine responsesA systems biology approach to the effect of aging, immunosenescence and vaccine responseThe weight of obesity on the human immune response to vaccinationFlu myths: dispelling the myths associated with live attenuated influenza vaccineThe clinician's guide to the anti-vaccinationists' galaxyImmunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responsesVaccines against avian influenza--a race against timeHumoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in HumansAttitudes toward and uptake of H1N1 vaccine among health care workers during the 2009 H1N1 pandemicExtended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunityGenome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipientsA genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine AdsorbedInfluenza vaccination and the elderly: pandemic preparedness.T-Cell epitope discovery for variola and vaccinia viruses.Confronting bioterrorism: physicians on the front line.Emerging Mumps Infection.Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel.Associations between measles antibody levels and the protein structure of class II human leukocyte antigens.Avian and pandemic influenza: an overview.Turkey versus guinea pig red blood cells: hemagglutination differences alter hemagglutination inhibition responses against influenza A/H1N1.Facing the challenges of influenza in healthcare settings: the ethical rationale for mandatory seasonal influenza vaccination and its implications for future pandemics.2009 H1N1 influenza.H5N1 Avian influenza: preventive and therapeutic strategies against a pandemic.Influenza vaccines: from surveillance through production to protection.The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns.New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.Calculating sample size estimates for RNA sequencing data.ReliefSeq: a gene-wise adaptive-K nearest-neighbor feature selection tool for finding gene-gene interactions and main effects in mRNA-Seq gene expression data.Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus.The overall safety profile of currently available vaccines directed against infectious diseases.3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome AnalyzerPolymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination.
P50
P98
Q22248117-50BCB415-E4A7-4982-AA1C-42C1FBD35F86Q24261327-A88D78F6-06CC-4BE1-939B-08D06E198CDAQ24261399-A13D8244-1CA6-4EBB-B894-682F633B2895Q24289396-981E3F15-F457-4DD3-9C4E-4B99C38A7194Q24290580-FE1E7AEF-F57E-45FB-86F3-30B49833516BQ24612100-D24DFB8C-3AF9-4177-BF20-8414B9A6E970Q24648874-75795788-1BC5-4A5E-A935-C0775A524AAAQ26739036-0A6FAD21-A7F4-4526-AC63-FF2021C3948CQ26823501-92DF6669-3452-45D9-9F77-49A3216A3D94Q26994749-B5F5775B-2BCE-45D5-A963-223EADB6C7B5Q28088540-55E05088-0C16-4120-88DB-3A2A2AA9EE26Q28263507-74D6C8B3-22F2-498F-9159-90902B15FC09Q28264526-4F308B53-5613-435E-BDF2-E223D1E3A6FDQ28285300-EE83FA39-7141-4B09-A879-F96A338A1B30Q28304382-C5EA8349-ADED-4B34-9BFD-8F1F529891D5Q28391301-18E8B119-76C0-4FA1-B4B0-BBFBF5DC19F8Q28395037-5A95D8AD-7679-475E-9A27-A679F6640278Q28750199-02E142B8-A020-44F2-9738-F8BB48D78DFEQ28943252-E2282A3C-701E-4BDE-965C-847398529DA2Q28943460-E13D0A08-BBCE-4C7C-A355-FEA0A383E88EQ30229051-86607410-6DB2-4F04-A41F-EF201FE635CEQ30230177-F7866B19-2C39-4C79-A7EE-28072E237678Q30233504-A9C12EBF-D1E1-4782-9509-F6F7916F670FQ30251549-A69D23E0-3667-4310-8DEF-883FDFC2DC17Q30310967-8C396C3F-3094-4315-94CF-D9D209077102Q30333088-C20A5B4D-2250-4C5F-A7E2-CC935550CDAEQ30359760-16DE7F8B-D935-4822-9758-2E8B52958CCAQ30362094-FC241770-2E11-4D65-8211-B2B41F0F7DBDQ30375048-6D7B685A-D57B-404E-8110-C26A7E6570DDQ30383437-79F63FE8-1448-4E44-89D5-4F9F3D56B620Q30384208-19BE80E1-7B05-4236-A75C-EEDBC623B07EQ30385118-51A957C9-FD7D-485A-8239-FFE5CDC35325Q30392669-33EEA1BE-EB54-401C-AD4F-1CFFAE8CC9CFQ30429431-B420500D-0C49-48FF-B9F2-A4E194C69090Q30662528-EC7A8879-B1C6-413A-9311-AC7738807B53Q30715874-B763F7BD-8A5B-4AE0-94C6-949480C897ACQ31007306-41543B38-8CEF-48CE-9994-8D4B72175A1BQ33149223-2F9311FC-5D12-4A94-850B-6B150CDB4088Q33516040-177BB9A5-18A4-4F38-AE65-D20A4E6E3087Q33556985-A7CC4CE1-30D4-46C5-8D97-4D1C884D7D4C
P50
description
American physician and vaccinologist
@en
bewerker
@nl
curatore editoriale statunitense
@it
editor estadounidense
@es
editor estadounidense
@gl
editor estatunidenc
@ca
editor estauxunidense
@ast
editor norte-americano
@pt
editore estatubatuarra
@eu
éditeur américain
@fr
name
Gregory Poland
@ast
Gregory Poland
@en
Gregory Poland
@es
Gregory Poland
@nl
type
label
Gregory Poland
@ast
Gregory Poland
@en
Gregory Poland
@es
Gregory Poland
@nl
prefLabel
Gregory Poland
@ast
Gregory Poland
@en
Gregory Poland
@es
Gregory Poland
@nl
P214
P244
P106
P21
P214
P244
P31
P734
P735
P7859
lccn-n99803205